Developments in haematological malignancies

Bookmark and Share
Published: 6 Jun 2016
Views: 1032
Dr Stephen Nimer - University of Miami, Miami, USA

Dr Nimer meets with ecancertv at ASCO 2016 to discuss haematological malignancies.

For more on cytarabine and daunorubicin, Dr Jeffery Lancet discusses them here.

Ibrutinib was approved for newly diagnosed CLL by the European Commission last week, our coverage of which can be found here.

Dr Antonio Palumbo's work with daratumamab is reviewed in his interview here, and our ASCO news coverage here.